Abstract

Polyhexamethylene biguanide (PHMB) is a broad-spectrum antiseptic which avoids many efficacy and toxicity problems associated with antimicrobials, in particular, it has a low risk of loss of susceptibility due to acquired antimicrobial resistance. Despite such advantages, PHMB is not widely used in wound care, suggesting more research is required to take full advantage of PHMB’s properties. We hypothesised that a nanofibre morphology would provide a gradual release of PHMB, prolonging the antimicrobial effects within the therapeutic window. PHMB:polyurethane (PU) electrospun nanofibre membranes were prepared with increasing PHMB concentrations, and the effects on antimicrobial activities, mechanical properties and host cell toxicity were compared. Overall, PHMB:PU membranes displayed a burst release of PHMB during the first hour following PBS immersion (50.5–95.9% of total released), followed by a gradual release over 120 h (≤25 wt % PHMB). The membranes were hydrophilic (83.7–53.3°), gradually gaining hydrophobicity as PHMB was released. They displayed superior antimicrobial activity, which extended past the initial release period, retained PU hyperelasticity regardless of PHMB concentration (collective tensile modulus of 5–35% PHMB:PU membranes, 3.56 ± 0.97 MPa; ultimate strain, >200%) and displayed minimal human cell toxicity (<25 wt % PHMB). With further development, PHMB:PU electrospun membranes may provide improved wound dressings.

Highlights

  • Preventing and stabilising infection is a global challenge that is growing within healthcare systems.In addition to being a major cause of death, slow healing increases costs and perpetuates patient suffering

  • They displayed superior antimicrobial activity, which extended past the initial release period, retained PU hyperelasticity regardless of Polyhexamethylene biguanide (PHMB) concentration and displayed minimal human cell toxicity (

  • PHMB was successfully incorporated within PU nanofibre membranes at concentrations ranging

Read more

Summary

Introduction

Preventing and stabilising infection is a global challenge that is growing within healthcare systems.In addition to being a major cause of death, slow healing increases costs and perpetuates patient suffering. With many populations still overusing antibiotics [3], research into non-antibiotic alternatives is essential

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call